Press release
Angina Pectoris Drugs Market: Achieving CAGR of 6.3% by 2029
Angina Pectoris Drugs Market
What Is The Projected Market Size Of The Global Angina Pectoris Drugs Market And Its Growth Rate?
The angina pectoris drugs market is observing strong growth, benefiting from the high prevalence of cardiovascular diseases and rising global obesity rates.
• The market grew from $12.32 billion in 2024 to $12.94 billion in 2025, reflecting a CAGR of 5.1%
• By 2029, the market size is estimated to reach $16.55 billion, indicating a CAGR of 6.3%
The market growth relies on advancements in precision medicine, increasing focus on preventive cardiology, variety in patient education initiatives, and research on novel therapeutic targets.
What Is Driving The Growth In The Angina Pectoris Drugs Market?
The increasing prevalence of cardiovascular diseases drives the angina pectoris drug market growth. Cardiovascular disorders such as coronary artery disease, high blood pressure, heart failure, and stroke impact the heart and blood vessels. The mounting prevalence of these ailments is attributed to an aging populace, unhealthy lifestyles, and the obesity publie health issue. Angina pectoris medications like nitrates, beta-blockers, and calcium channel blockers effectively relieve chest pain caused by insufficient blood flow to the heart, thereby improving patients' quality of life. Thus, the increasing prevalence of cardiac conditions propels the angina pectoris drug market expansion.
Request A Free Sample Copy at https://www.thebusinessresearchcompany.com/sample.aspx?id=10797&type=smp
Who Are the Key Players Driving Angina Pectoris Drugs Market Growth?
Key companies in the angina pectoris drugs market report include:
• Astellas Pharma Inc.
• Bayer AG
• Novartis AG
• AstraZeneca PLC
• Bausch Health Companies Inc.
• Merck & Co Inc.
• Eli Lilly and Company
• Pfizer Inc.
• Abbott Laboratories
• Sun Pharmaceutical Industries Limited
• Sanofi SA
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Johnson & Johnson
• AERIE PHARMACEUTICALS INC.
• AbbVie Inc.
• Amgen Inc.
• Gilead Sciences Inc.
• GlaxoSmithKline plc
• H. Lundbeck A/S
• Ipsen S.A.
• Lupin Pharmaceuticals Inc.
• Merck KGaA
• Otsuka Pharmaceutical Co. Ltd.
• Regeneron Pharmaceuticals Inc.
• Servier Laboratories
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.
What Are The Key Trends In The Angina Pectoris Drugs Market?
Key trends in the market include:
• Using telemedicine for remote monitoring
• Real-world evidence and outcome studies
• Patient-centric medication education
• Strategic alliances for market access
• Regulatory advances
• Expedited approvals
What Are The Segments Of The Global Angina Pectoris Drugs Market?
The angina pectoris drugs market is categorized by
• Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs
• Indication: Stable Angina, Unstable Angina, Prinzmetal's Angina
• Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations
• End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Which Region Leads The Angina Pectoris Drugs Market?
In 2024, North America was the largest region in the angina pectoris drugs market. However, Asia-Pacific is anticipated to be the fastest-growing region during the forecast period. The angina pectoris drugs market report covers Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery at https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report
What Is Covered In The Angina Pectoris Drugs Market Global Market Report?
- Market Size Analysis: Analyze the Angina Pectoris Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Angina Pectoris Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Angina Pectoris Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Angina Pectoris Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report at https://www.thebusinessresearchcompany.com/Customise?id=10797&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
Learn More About the Business Research Company. With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Using 1,500,000 datasets, in-depth secondary research, and unique insights from industry leaders, you can stay ahead with information.
Our flagship product, the Global Market Model (GMM), delivers comprehensive and updated forecasts to facilitate informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angina Pectoris Drugs Market: Achieving CAGR of 6.3% by 2029 here
News-ID: 3829221 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Angina
Angina Market Key Players, Trends & Forecast to 2034
The Angina Market is experiencing steady growth worldwide as heart disease cases rise and healthcare providers adopt advanced diagnostic tools, novel anti-anginal medications, and cutting-edge interventional cardiology treatments. With precision diagnostics, long-acting drug therapies, and improved cardiac revascularization techniques, the market is set for substantial expansion through 2034.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/52004
1. What Is Angina? (Keyword Definition)
Angina pectoris-commonly known as angina-is chest pain or discomfort caused…
Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pecto …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Angina Pectoris Drugs Market Size By 2025?
The market size for angina pectoris drugs has experienced consistent growth in the past few years. The market is projected to expand from $12.32 billion in 2024 to $12.88 billion in 2025, representing a compound annual growth rate…
Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus on improving myocardial efficiency and reducing ischemic burden, emerging therapies-including metabolic modulators, nitric oxide donors, and gene therapies-aim to offer more effective symptom relief and reduce cardiovascular events. Innovations are targeting both stable and microvascular angina forms, addressing the significant unmet needs in chronic angina…
What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Ar …
What Are the Projections for the Size and Growth Rate of the Angina Market?
The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as a…
Angina Pectoris - Drug Pipeline Landscape, 2022
Global Angina Pectoris Market report from Global Insight Services is the single authoritative source of intelligence on angina pectoris market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Angina Pectoris - Drug Pipeline Landscape, 2022
Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. Angina is mainly of four types: stable angina, unstable angina, microvascular angina, and vasospastic or variant angina.
Angina is caused due to the built…
